Longeveron (LGVN) Revenue (2020 - 2026)
Longeveron's (LGVN) quarterly Revenue came in at $398000.0 in Q1 2026, up 4.46% year-on-year from $381000.0 in Q1 2025, and up 9.04% quarter-over-quarter from $365000.0 in Q4 2025.
Longeveron (LGVN) Revenue (2020 - 2026) Analysis & Trends
Longeveron's Revenue history runs 7 years deep, the most recent figure standing at $398000.0 for Q1 2026.
- On a quarterly basis, Revenue rose 4.46% year-over-year to $398000.0 in Q1 2026; TTM through Mar 2026 was $1.2 million, a 45.35% decrease from a year earlier, with the FY2025 full-year figure at $1.2 million, down 49.87% from the prior year.
- Revenue advanced to $398000.0 in Q1 2026 per LGVN's latest filing, from $365000.0 in the prior quarter.
- Across five years, Revenue topped out at $773000.0 in Q3 2024 and bottomed at $63000.0 in Q4 2023.
- The 5-year median for Revenue is $316000.0 (2025), against an average of $335000.0.
- Across the five-year window, Revenue soared 857.14% in 2024 and slumped 82.28% in 2025, its largest moves.
- Year by year, Revenue stood at $121000.0 in 2022, then slumped by 47.93% to $63000.0 in 2023, then surged by 857.14% to $603000.0 in 2024, then tumbled by 39.47% to $365000.0 in 2025, then advanced by 9.04% to $398000.0 in 2026.
- Per Business Quant, the three latest LGVN Revenue figures stand at $398000.0 (Q1 2026), $365000.0 (Q4 2025), and $137000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Longeveron | 14.87 Bn | 14.86 Bn | 264,000.00 | 398,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 398,000.00 |
| Dec 31, 2025 | 365,000.00 |
| Sep 30, 2025 | 137,000.00 |
| Jun 30, 2025 | 316,000.00 |
| Mar 31, 2025 | 381,000.00 |
| Dec 31, 2024 | 603,000.00 |
| Sep 30, 2024 | 773,000.00 |
| Jun 30, 2024 | 468,000.00 |
| Mar 31, 2024 | 548,000.00 |
| Dec 31, 2023 | 63,000.00 |
| Sep 30, 2023 | 150,000.00 |
| Jun 30, 2023 | 217,000.00 |
| Mar 31, 2023 | 279,000.00 |
| Dec 31, 2022 | 121,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 466,000.00 |
| Mar 31, 2022 | 310,000.00 |
| Dec 31, 2021 | 209,000.00 |
| Sep 30, 2021 | 232,000.00 |
| Jun 30, 2021 | 489,000.00 |